Japan Tissue Engineering: Financial report for the first quarter ending in March 2025.
Japan Tissue Engineering: Overview of Q1 2025 earnings report.
Japan Tissue Engineering: March 2025 First Quarter Fiscal Results Announcement [Japanese Standards] (Non-consolidated)
Japan Tissue Engineering: The skin sensitization test method, "EpiSensA," which uses the human 3D-cultured epidermal model "Labosite Epi-Model 24," has been standardized worldwide.
Japan Tissue Engineering: Aichi Prefecture cooperates with 'Science Practicum Experience Research Labs' - high school students in the prefecture experience cutting-edge science and technology at universities and companies.
Japan Tissue Engineering: Regarding matters related to dominant shareholders.
Japan Tissue Engineering: Interim report
Japan Tissue Engineering: Internal Control Report - 26th Term (2023/04/01 - 2024/03/31)
Japan Tissue Engineering: Confirmation letter
Japan Tissue Engineering: Financial Report - 26th Term (2023/04/01 - 2024/03/31)
Japan Tissue Engineering: Report on corporate governance as of June 19, 2024.
Japan Tissue Engineering: Announcements of organizational changes and personnel changes
Japan Tissue Engineering: Submission of an application for approval of partial changes to in-house cultivated cartilage (JACC).
Japan Tissue Engineering: Submission of part modification approval application for autologous cultured cartilage "Jack" towards expanded indication for osteoarthritis of the knee joint.
Japan Tissue Engineering: Ritsumeikan University has signed an agreement regarding cooperation with the Faculty of Pharmacy – promoting the development of next-generation personnel in regenerative medicine and deepening industry-academia exchanges.
Japan Tissue Engineering: Announcements of individual stocks: Notice of adoption of New Aichi Creation Research and Development Grant in 2024.
Japan Tissue Engineering: 2024 26th Annual General Meeting of Shareholders materials (individual notes table)
Japan Tissue Engineering: Notice of Convocation of the 26th Annual General Meeting of Shareholders in 2024
Japan Tissue Engineering: Financial results presentation materials for the fiscal year ending 2024/3
Japan Tissue Engineering: Matters relating to business plans and growth potential
No Data